ClinicalTrials.govpublic full text
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
hematologic malignancies, acute myeloid leukemia, lymphoid leukemia, chronic myeloid leukemia, hodgkin's disease, non-hodgkin's lymphoma, myelodysplastic syndromes, tetraethylenepentamine, umbilical cord blood stem cell transplantation, hematological malignancies, acute lymphoid leukemia, subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 916382
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.